calcipotriene and betamethasone dipropionate

FDA Drug Profile — TACLONEX, ENSTILAR, calcipotriene and betamethasone dipropionate

Drug Details

Generic Name
calcipotriene and betamethasone dipropionate
Brand Names
TACLONEX, ENSTILAR, calcipotriene and betamethasone dipropionate
Application Number
NDA022185
Sponsor
LEO Pharma Inc.
NDC Codes
3
Dosage Forms
SUSPENSION, AEROSOL, FOAM
Routes
TOPICAL
Active Ingredients
BETAMETHASONE DIPROPIONATE, CALCIPOTRIENE HYDRATE, CALCIPOTRIENE MONOHYDRATE, CALCIPOTRIENE

Indications and Usage

1 INDICATIONS AND USAGE Calcipotriene and Betamethasone Dipropionate Ointment is indicated for the topical treatment of plaque psoriasis in patients 12 years of age and older. Calcipotriene and Betamethasone Dipropionate Ointment is a vitamin D analogue and corticosteroid combination product indicated for the topical treatment of plaque psoriasis in patients 12 years of age and older. ( 1 )